Noxious Influences Affecting Fetus or Newborn

Why This Topic Matters

Accurate reporting of maternal exposure-related conditions depends on understanding how the classification changed and which substance categories are separately tracked. The topic is important for medical coders and auditors working with perinatal, newborn, and maternal documentation.

Article Sections

1. Effective date and code expansion

   Introduces the effective date of the update and the expansion of the fetal/newborn exposure category. It explains the general purpose of separating certain substance exposures for tracking.

2. Background on fetal effects of maternal substance exposure

   Summarizes the broader clinical context for maternal exposure during pregnancy and its potential effects on fetal development. It also references general sources and research discussed in the article.

3. Anticonvulsants and antimetabolic agents

   Describes the substance groups added in the update and notes examples mentioned in the article. The section places those groups within the larger exposure category.

4. Clinical example and coding question

   Presents a newborn scenario involving maternal treatment exposure and asks how the case should be coded. The section shows how the article applies the classification update to a practical documentation example.